Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Sopharma AD - Filing #6022429

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—	—	—	—		—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	681 487 BGN	—	—	—	—	—	—	—	—	633 746 BGN	—	—	—	—	—	—
Current assets	572 491 BGN	—	—	—	—	—	—	—	—	571 232 BGN	—	—	—	—	—	—
Non-current liabilities	129 998 BGN	—	—	—	—	—	—	—	—	122 218 BGN	—	—	—	—	—	—
Current liabilities	407 346 BGN	—	—	—	—	—	—	—	—	423 892 BGN	—	—	—	—	—	—
Revenue	—	—	—	—	1 663 016 BGN	—	—	—	—	—	—	—	—	—	1 603 310 BGN	—
Profit (loss)	—	71 121 BGN	—	—	76 333 BGN	71 121 BGN	5 212 BGN	—	2 207 BGN	—	—	—	—	89 496 BGN	91 703 BGN	89 496 BGN
Other comprehensive income	—	6 011 BGN	8 92 BGN	1 047 BGN	5 868 BGN	1 355 BGN	143,000 BGN	5 427 BGN	4 7 9 BGN	—	3 55 BGN	3 367 BGN	9 485 BGN	12 474 BGN	11 995 BGN	2 3 BGN
Comprehensive income	—	65 110 BGN	8 92 BGN	1 047 BGN	70 465 BGN	72 476 BGN	5 355 BGN	5 427 BGN	1 728 BGN	—	3 55 BGN	3 367 BGN	9 485 BGN	101 970 BGN	103 698 BGN	89 473 BGN